HK1012416A1 - Immunomodulators - Google Patents

Immunomodulators

Info

Publication number
HK1012416A1
HK1012416A1 HK98113556A HK98113556A HK1012416A1 HK 1012416 A1 HK1012416 A1 HK 1012416A1 HK 98113556 A HK98113556 A HK 98113556A HK 98113556 A HK98113556 A HK 98113556A HK 1012416 A1 HK1012416 A1 HK 1012416A1
Authority
HK
Hong Kong
Prior art keywords
immunomodulators
Prior art date
Application number
HK98113556A
Other languages
English (en)
Inventor
Christian Gronhoj Larsen
Borbala Gesser
Original Assignee
Steeno Res Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Res Group As filed Critical Steeno Res Group As
Publication of HK1012416A1 publication Critical patent/HK1012416A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK98113556A 1994-07-05 1998-12-16 Immunomodulators HK1012416A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05
PCT/DK1995/000227 WO1996001318A1 (en) 1994-07-05 1995-06-07 Immunomodulators

Publications (1)

Publication Number Publication Date
HK1012416A1 true HK1012416A1 (en) 1999-07-30

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113556A HK1012416A1 (en) 1994-07-05 1998-12-16 Immunomodulators

Country Status (28)

Country Link
US (3) US6159937A (xx)
EP (2) EP0769054B1 (xx)
JP (1) JPH10502249A (xx)
CN (1) CN1216992C (xx)
AP (1) AP690A (xx)
AT (1) ATE195003T1 (xx)
AU (1) AU686816B2 (xx)
BR (1) BR9508243A (xx)
CA (1) CA2194444C (xx)
CZ (1) CZ1497A3 (xx)
DE (1) DE69518156T2 (xx)
DK (1) DK0769054T3 (xx)
EE (1) EE03451B1 (xx)
ES (1) ES2148525T3 (xx)
FI (1) FI970009A (xx)
GR (1) GR3034628T3 (xx)
HK (1) HK1012416A1 (xx)
HU (1) HU220344B (xx)
MX (1) MX9606537A (xx)
NO (1) NO970020L (xx)
NZ (1) NZ287406A (xx)
PL (1) PL181042B1 (xx)
PT (1) PT769054E (xx)
RO (1) RO118758B1 (xx)
RU (1) RU2218348C2 (xx)
SK (1) SK283096B6 (xx)
UA (1) UA57702C2 (xx)
WO (1) WO1996001318A1 (xx)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
CA2253313A1 (en) * 1996-05-02 1997-11-06 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
WO1999018942A1 (en) * 1997-10-10 1999-04-22 Imperial College Innovations Ltd. Use of csaidtm compounds for the management of uterine contractions
CA2356010A1 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
EP1183361B1 (en) * 1999-05-25 2005-03-30 CANJI, Inc. Gene therapy of pulmonary disease
AU2002220257A1 (en) * 2000-12-07 2002-06-18 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
WO2003068152A2 (en) * 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
CA2477780A1 (en) * 2002-03-05 2003-09-18 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
CA2524534C (en) * 2003-05-15 2012-12-11 Sek Chung Fung Methods and compositions for the prevention and treatment of sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
WO2005082396A2 (en) * 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Use of mda-7 to inhibit infection by pathogenic organisms
WO2005087793A2 (en) 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
JP2008531481A (ja) * 2005-02-08 2008-08-14 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム 癌の治療のための、ｍｄａ−７を含む組成物および方法
WO2006119170A2 (en) * 2005-05-02 2006-11-09 Avigen, Inc. Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
HUE041875T2 (hu) 2005-05-31 2019-06-28 Univ Colorado Regents Eljárás génbejuttatásra
BRPI0713484A2 (pt) * 2006-06-21 2012-11-06 Apogenix Gmbh expressão diferencial de citocina em cáncer humano
US20100086515A1 (en) * 2006-07-06 2010-04-08 Apogenix Gmbh Human il-4 muteins in cancer therapy
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
US8513185B2 (en) * 2009-10-13 2013-08-20 Alexander B. Sigalov Inhibition of TREM receptor signaling with peptide variants
CA2828504A1 (en) * 2011-03-14 2012-09-20 Serodus Asa Antagonists of the interleukin-1 receptor
DK2814843T3 (da) 2012-02-13 2020-06-22 Agency Science Tech & Res IL-ß-NEUTRALISERENDE HUMANE MONOKLONALE ANTISTOFFER
EP3369435B1 (en) 2013-07-18 2019-09-04 Xalud Therapeutics, Inc. Composition for the treatment of inflammatory joint disease
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
US20180206726A1 (en) 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
CA3054156A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
US20220249814A1 (en) 2018-11-19 2022-08-11 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
CN113711038A (zh) * 2019-01-31 2021-11-26 积水医疗株式会社 用于生物样品中游离aim的免疫分析方法及用于检测对象中nash的方法
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
EP0600970B1 (en) * 1991-08-06 1999-12-08 Schering Corporation Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
CA2131524A1 (en) * 1992-03-04 1993-09-16 Maria-Grazia Roncarolo Use of interleukin-10 to suppress graft-vs.-host disease
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
DK0671933T3 (da) * 1992-08-20 1998-09-23 Schering Corp Hidtil ukendte anvendelser af IL-10
JPH08507930A (ja) * 1993-07-26 1996-08-27 シェリング・コーポレーション ヒトインターロイキン−１０のアゴニストおよびアンタゴニスト

Also Published As

Publication number Publication date
JPH10502249A (ja) 1998-03-03
ES2148525T3 (es) 2000-10-16
HU220344B (hu) 2001-12-28
CA2194444C (en) 2003-01-14
NZ287406A (en) 1998-07-28
PT769054E (pt) 2000-11-30
EP0769054A1 (en) 1997-04-23
US6168791B1 (en) 2001-01-02
RO118758B1 (ro) 2003-10-30
SK161496A3 (en) 1997-08-06
CN1159830A (zh) 1997-09-17
PL319429A1 (en) 1997-08-04
US6159937A (en) 2000-12-12
AP690A (en) 1998-10-16
BR9508243A (pt) 1997-10-21
DE69518156T2 (de) 2001-01-11
EP1013764A1 (en) 2000-06-28
HU9603615D0 (en) 1997-02-28
CN1216992C (zh) 2005-08-31
GR3034628T3 (en) 2001-01-31
DK0769054T3 (da) 2000-11-13
DE69518156D1 (de) 2000-08-31
UA57702C2 (uk) 2003-07-15
EE9700029A (et) 1997-08-15
AU686816B2 (en) 1998-02-12
FI970009A0 (fi) 1997-01-02
FI970009A (fi) 1997-03-04
US6599501B1 (en) 2003-07-29
RU2218348C2 (ru) 2003-12-10
CZ1497A3 (en) 1997-05-14
WO1996001318A1 (en) 1996-01-18
ATE195003T1 (de) 2000-08-15
MX9606537A (es) 1997-12-31
CA2194444A1 (en) 1996-01-18
NO970020D0 (no) 1997-01-03
EP0769054B1 (en) 2000-07-26
PL181042B1 (pl) 2001-05-31
AP9700962A0 (en) 1997-04-30
HUT76673A (en) 1997-10-28
NO970020L (no) 1997-03-05
AU2612195A (en) 1996-01-25
SK283096B6 (sk) 2003-02-04
EE03451B1 (et) 2001-06-15

Similar Documents

Publication Publication Date Title
PL319429A1 (en) Immunomodulators
DE69512030D1 (en) Cerebral-dilator
DE59503739D1 (en) Polymer-sensor
DE69502271D1 (en) Afterabtrennung
DE69511086D1 (en) Pyrimidinderivate
DE69504528D1 (en) Quenchkühler
DE69429543D1 (en) Koagulationszange
DE59503634D1 (en) Friercontainer
DE69512382D1 (en) Deodorierte thermoplaste
DE59509661D1 (en) Heterocyclylbenzonitrile
AU122938S (en) Breadbox
DE69508761D1 (en) Haloalkylierungsverfahren
ZA952219B (en) Insert
DE59508136D1 (en) Phenylthio-oxazolin-derivate
DE69506730D1 (en) Differentialer antriebsmechanismus
SI0769054T1 (en) Immunomodulators
DE69504062D1 (en) Spandexlieferspule
DE59510739D1 (en) N-cyanoaryl-stickstoffheterocyclen
DE69502834D1 (en) Vinylperfluorcyclopropanpolymere
DE59503452D1 (en) Piezoresistiver widerstand
GB2285529B (en) Bar-b-card
CA73835S (en) Air-purifier
CA73798S (en) Air-purifier
AU125925S (en) Insert
HU9401050D0 (en) Solid logic-toy

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050607